PA-MSHA in combination with EGFR tyrosine kinase inhibitor: A new strategy to overcome the drug resistance of non-small cell lung cancer cells
Xinmin Zhao(Southern Medical University), Xiaolong Fu(Fudan University Shanghai Cancer Center)
Cited by 12
Related Papers
MicroRNA‑139‑5p improves sepsis‑induced lung injury by targeting Rho‑kinase1
|Experimental and Therapeutic Medicine|2021|15
PA-MSHA inhibits proliferation and induces apoptosis in human non-small cell lung cancer cell lines with different genotypes
|Molecular Medicine Reports|2016|11